Why the study?
Does pharmacological treatment (statins or beta blockers) improve long-term outcomes and survival in patients with aortic dissection?
Does pharmacological treatment (statins or beta blockers) improve long-term outcomes and survival in patients with aortic dissection?
Statins may improve outcomes in medically managed aortic dissection, while beta blockers may improve survival in surgically managed patients, though randomized trials are needed.
Answers are grounded in this paper and cite their sources.
May support differential pharmacotherapy by management strategy in aortic dissection; hypothesis-generating and requires dedicated RCTs before practice change.
Statin treatment was associated with favourable long-term outcome in medically managed AD patients, whereas treatment with beta blocker was associated with higher survival only in surgically managed AD patients. Statin use as well as optimal antihypertensive therapy in the chronic stage of the disease need to be further analysed, preferably in randomised controlled trials.
No takes yet. Share an insight, caveat, or question.
Smedberg et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: